Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion type Assertion NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_head.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_provenance.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion evidence source_evidence_literature NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_provenance.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion SIO_000772 23197570 NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_provenance.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion wasDerivedFrom befree-2016 NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_provenance.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion wasGeneratedBy ECO_0000203 NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_provenance.